Potential Agents against Plasma Leakage
ISRN Pharmacology · 2011
DOI: 10.5402/2011/975048 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Pharmacology, 2011. Verfasst von Jeanne Adiwinata Pawitan. Beteiligte Einrichtung: Department of Histology, Faculty of Medicine, University of Indonesia, Jl. Salemba 6, Jakarta 10430, Indonesia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the deleterious effect of plasma leakage. Some of the various substances and proteins such as focal adhesion kinase (FAK), the Rho GTPases, protein kinase A, and caveolin-1 have dual actions; therefore they are not suitable for therapy. However, sphingosine 1phosphate and its receptor agonists, Angiopoetin-1, Slit, and Bbeta15–42 may be promising.
Autor:innen und Institutionen
- Department of Histology, Faculty of Medicine, University of Indonesia, Jl. Salemba 6, Jakarta 10430, Indonesia.
Zitieren
APA
Pawitan, J. A. (2011). Potential Agents against Plasma Leakage. ISRN Pharmacology. https://doi.org/10.5402/2011/975048
Vancouver
Pawitan JA. Potential Agents against Plasma Leakage. ISRN Pharmacology. 2011. doi:10.5402/2011/975048
BibTeX
@article{Pawitan2011,
author = {Pawitan, Jeanne Adiwinata},
title = {Potential Agents against Plasma Leakage},
journal = {ISRN Pharmacology},
year = {2011},
doi = {10.5402/2011/975048}
}
EUVIMED